alpha-Glucosidase-IN-110 is a selective and orally active competitive inhibitor of alpha-Glucosidase with an IC50 of 7.09 µM and a Ki of 6.9 µM. alpha-Glucosidase-IN-110 can reduce fasting blood glucose levels, improve glucose tolerance, and restore the histomorphology of liver and pancreatic tissues in diabetic rat models. alpha-Glucosidase-IN-110 can be used for the research of diabetes[1].
Molekulargewicht:
517.00
Formel:
C26H21ClN6O2S
Target-Kategorie:
Glycosidase
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
